Hedge Fund - OrbiMed Advisors
Humana Inc (HUM)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2023 - Q4 (2023-12-31) | $50,313,319 | 1% | 109,900 | $492.89 |
2 | 2023 - Q3 (2023-09-30) | $166,633,100 | 3.53% | 342,500 | $469.94 |
3 | 2023 - Q2 (2023-06-30) | $155,914,231 | 2.82% | 348,700 | $503.42 |
4 | 2023 - Q1 (2023-03-31) | $169,279,902 | 3.32% | 348,700 | $494.33 |
5 | 2022 - Q4 (2022-12-31) | $178,600,653 | 3.41% | 348,700 | $525.59 |
6 | 2022 - Q3 (2022-09-30) | $169,186,000 | 3.14% | 348,700 | $486.43 |
7 | 2022 - Q2 (2022-06-30) | $171,173,000 | 3.1% | 365,700 | $444.95 |
8 | 2022 - Q1 (2022-03-31) | $166,104,000 | 2.69% | 381,700 | $418.32 |
9 | 2021 - Q4 (2021-12-31) | $147,647,000 | 1.89% | 318,300 | $442.52 |
10 | 2021 - Q3 (2021-09-30) | $130,365,000 | 1.43% | 335,000 | $424.45 |
11 | 2021 - Q2 (2021-06-30) | $148,311,000 | 1.5% | 335,000 | $436.88 |
12 | 2021 - Q1 (2021-03-31) | $131,477,000 | 1.22% | 313,600 | $399.18 |
13 | 2020 - Q4 (2020-12-31) | $117,378,000 | 1.02% | 286,100 | $415.77 |
14 | 2020 - Q3 (2020-09-30) | $116,013,000 | 1.45% | 280,300 | $402.23 |
15 | 2020 - Q2 (2020-06-30) | $108,686,000 | 1.53% | 280,300 | $374.15 |
16 | 2020 - Q1 (2020-03-31) | $88,020,000 | 1.47% | 280,300 | $337.27 |
17 | 2019 - Q4 (2019-12-31) | $143,639,000 | 2.05% | 391,900 | $317.17 |
18 | 2019 - Q3 (2019-09-30) | $46,481,000 | 0.88% | 181,800 | $280.37 |
19 | 2019 - Q2 (2019-06-30) | $0 | 0% | 0 | $253.60 |
20 | 2019 - Q1 (2019-03-31) | $55,940,000 | 0.86% | 210,300 | $288.17 |
21 | 2018 - Q4 (2018-12-31) | $59,158,000 | 1.09% | 206,500 | $317.04 |
22 | 2018 - Q3 (2018-09-30) | $133,038,000 | 1.6% | 393,000 | $324.90 |
23 | 2018 - Q2 (2018-06-30) | $21,608,000 | 0.25% | 72,600 | $292.84 |
24 | 2017 - Q3 (2017-09-30) | $0 | 0% | 0 | $245.02 |
25 | 2017 - Q2 (2017-06-30) | $185,494,000 | 1.94% | 770,900 | $226.40 |
26 | 2017 - Q1 (2017-03-31) | $153,018,000 | 1.73% | 742,300 | $206.75 |
27 | 2016 - Q4 (2016-12-31) | $170,651,000 | 2.17% | 836,400 | $190.72 |
28 | 2016 - Q3 (2016-09-30) | $74,913,000 | 0.85% | 423,500 | $173.54 |
29 | 2016 - Q2 (2016-06-30) | $61,105,000 | 0.63% | 339,700 | $177.63 |
30 | 2016 - Q1 (2016-03-31) | $62,148,000 | 0.65% | 339,700 | $173.48 |
31 | 2013 - Q2 (2013-06-30) | $0 | 0% | 0 | $78.93 |
32 | 2013 - Q1 (2013-03-31) | $9,675,000 | 0.22% | 140,000 | $71.52 |
33 | 2012 - Q4 (2012-12-31) | $39,874,000 | 1.22% | 581,000 | $70.15 |
34 | 2012 - Q3 (2012-09-30) | $49,007,000 | 1.4% | 698,600 | $70.20 |
35 | 2012 - Q1 (2012-03-31) | $69,314,000 | 2.05% | 749,500 | $88.96 |
36 | 2011 - Q4 (2011-12-31) | $75,178,000 | 2.46% | 858,100 | $82.56 |
37 | 2011 - Q3 (2011-09-30) | $64,366,000 | 2.38% | 885,000 | $76.02 |
38 | 2011 - Q2 (2011-06-30) | $54,799,000 | 1.01% | 680,400 | $76.61 |
39 | 2011 - Q1 (2011-03-31) | $46,951,000 | 1.58% | 671,300 | $61.22 |
40 | 2010 - Q4 (2010-12-31) | $15,327,000 | 0.55% | 280,000 | $55.98 |
The displayed share prices are average quarterly stock market prices.